# Safety and Efficacy Study of rEV131 in Allergic Rhinitis

> **NCT00247520** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Evolutec Group** · enrollment: 112 (—)

## Conditions studied

- Hay Fever

## Interventions

- **DRUG:** topical nasal rEV131

## Key facts

- **NCT ID:** NCT00247520
- **Lead sponsor:** Evolutec Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-05
- **Primary completion:** —
- **Final completion:** 2005-08
- **Target enrollment:** 112 (—)
- **Last updated:** 2005-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00247520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00247520, "Safety and Efficacy Study of rEV131 in Allergic Rhinitis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00247520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*